Fri.Dec 22, 2023

article thumbnail

Many Patients With Moderate to Severe AD Demonstrate Inadequate Disease Control with Systemic Therapies After 3 to 12 Months of Use

Dermatology Times

The study findings were presented in a poster at the 2023 Revolutionizing Atopic Dermatitis Virtual Conference.

article thumbnail

Wellness Weekends to Explore in 2024

Salon Today

In need of a little ME time in the New Year? Here are some resort spas that are answering the call with wellness weekends in gorgeous destinations with activities designed to replenish.

59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Discovering Dermatology Times: December 2023

Dermatology Times

Learn more about the in-depth topics covered in the December 2023 print issue of Dermatology Times.

article thumbnail

Vagaro Launches MySite, A Website That Updates Itself

Salon Today

With the launch of MySite, offers unlimited customization options to showcase a business’ unique brand offerings and streamlines a powerful e-commerce opportunity for businesses.

article thumbnail

Jacana Debuts Wellness Collection in the United States

Skin Inc

Jacana products, previously found only in luxury spas in Jamaica, including GoldenEye, are now available for the first time in the United States.

52
article thumbnail

Booksy Amplifies Local Initiative "Heat the Streets" to Support Sacramento Community

Salon Today

Booksy is partnering with United Barbers Club for the "Heat the Streets" initiative, a community-focused campaign that runs every Thanksgiving and Christmas, aiming to provide warmth and support to those in need in the Sacramento, CA area.

45

More Trending

article thumbnail

The Weekly Roundup: December 18-22

Dermatology Times

ICYMI, this week we had articles about vitiligo onset following COVID-19 vaccination, a Revolutionzing Vitiligo interview with Nanette Silverberg, MD, the FDA approval of Filsuvez for the treatment of partial thickness wounds related to dystrophic junctional and epidermolysis bullosa, and more.

article thumbnail

Skin Inc. Will Be Back After New Year's Day

Skin Inc

From all of us at Skin Inc., have a happy and safe holiday!

52
article thumbnail

Post Hoc Analyses Examine Real-World Efficacy and Safety of Tirbanibulin in Actinic Keratoses

Dermatology Times

The analyses were published in the Journal of the European Academy of Dermatology and Venereology.

Safety 41
article thumbnail

Study: AD, OCD Linked 

The Dermatology Digest

People with atopic dermatitis (AD) may be up to three times as likely to develop obsessive-compulsive disorder (OCD), according to a research letter published in the December 2023 issue of the Archives of Dematological Research. When Yale School of Medicine researchers examined data from more than 214,000 participants in the All of Us Research Program, they found that people with AD were at 2.87-fold increased risk for OCD when compared to matched controls.

article thumbnail

Study Examines Psychological Comorbidities Among Acne Patients Using Isotretinoin

Dermatology Times

The most prevalent psychological disorder among patients was anxiety.

41
article thumbnail

Is an Acne Vaccine on the Horizon?

The Dermatology Digest

A new vaccine targeting a variant of hyaluronidase may reduce acne-related inflammation, according to research in mice in Nature Communications. Researchers identified two variants of hyaluronidase, an enzyme produced by Cutibacterium acnes (C. acnes). One variant, called HylA, is strictly made by C. acnes that are associated with acne. The other variant (HylB) is made by C. acnes associated with healthy skin.

Sebum 36
article thumbnail

Pointers With Portela: Topical Steroid Withdrawal

Dermatology Times

In this week’s Pointers With Portela, the 208SkinDoc reviews a patient case of topical steroid withdrawal.

36
article thumbnail

Differences in Anti-PD-1/CTLA-4 and Anti-PD-1/LAG-3 Reported in Recent Study

Dermatology Times

The study examined the mechanisms of action associated with immune checkpoint inhibitor combination therapies.

Therapy 36
article thumbnail

Case 1: Female, 56 Years Old

Dermatology Times

Peter Lio, MD, presents the case of a 56-year-old female with a history of severe atopic dermatitis and very dry skin. Dr. Lio discusses the significance of accurate disease diagnosis, tools for assessing severity, and the array of treatment options available for this patient. He emphasizes the importance of shared decision-making in managing the condition.

article thumbnail

Case 2: Female, 45 Years Old With Atopic Dermatitis

Dermatology Times

An expert in the management of skin conditions highlights the case of a 45-year-old female with severe pruritus, erythematous rash, and lichenification across multiple body areas, worsened by recent work-related stress from a promotion. Dr. Lio offers insights into managing such patients and shares practical tips for a streamlined prescription process.